In this second introductory video for the myRXAdvocate program, myMatrixx Chief Clinical Officer Phil Walls takes a closer look at the concept of pharmacovigilance. This term was introduced by the FDA and describes a proactive approach to drug safety and efficacy. Learn more about the background of pharmacovigilance and how myRXAdvocate was designed to embody this important idea.